Follow-up of a Malawian RCT in 137 healthy adults rechallenged with pneumococcus 6B one year after vaccination: PCV13 vs placebo reduced experimental carriage (adjusted RR 0.27; 73% protection), with weaker protection in previous carriers.
RCTn = 137
Chirwa et al. Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage at 1-year post-vaccination on rechallenge with Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a controlled human infection study and longitudinal follow-up of a randomised controlled trial